EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutknecht, D. R
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gutknecht, D. R
Evidence-Based Medicine 2004; 9:86
© 2004 BMJ Publishing Group Ltd.


Therapeutics

Topical capsaicin cream was effective for chronic idiopathic intractable pruritis ani

Lysy J, Sistiery-Ittah M, Israelit Y, et al. Topical capsaicin—a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study. Gut 2003;52:1323–6.[Abstract/Free Full Text]

Q In patients with chronic idiopathic intractable pruritus ani, what is the effectiveness of topical capsaicin?

Clinical impact ratings GP/FP/Primary care ******{star}

Key Words: pruritus ani • antipruritics

The first 150 words of the full text of this article appear below.

METHODS
Design: randomised, placebo controlled, crossover trial.

Allocation: concealed.*

Blinding: blinded (patients and healthcare providers).*

Follow up period: 4 and 9 weeks.

Setting: proctological outpatient clinics in a hospital and affiliated ambulatory clinic in Jerusalem, Israel.

Patients: 44 patients (mean age 50 y, 55% women) who had chronic idiopathic anal itching for >=3 months that had not responded to traditional treatment.

Intervention: a thin layer of perianal topical capsaicin cream, 0.006% 3 times each day for 4 weeks (n = 22) or menthol cream 1% (placebo) (n = 22). After a 1 week washout period, patients received the alternative treatment for 4 weeks. No patients received topical steroids or anaesthetics during the study.

Outcomes: clinical response (itching scores of 1 = no symptoms or 2 = nearly complete symptomatic relief with sporadic episodes of mild itching; scores of 3–5 were classified as negative responses) and side effects (burning sensation after application, . . . [Full text of this article]

David R Gutknecht, MD

Geisinger Medical Center
Danville, Pennsylvania, USA







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.